Your email has been successfully added to our mailing list.

×
0 -0.00148148148148145 -0.00148148148148145 -0.000740740740740725 -0.00370370370370362 -0.0125925925925926 -0.0125925925925926 -0.0125925925925926
Stock impact report

Novartis Lawsuit Accuses Amgen Of Trying To Welsh On Migraine Deal [Investor's Business Daily]

ALDER BIOPHARMACEUTICALS INC (ALDR) 
Last alder biopharmaceuticals inc earnings: 8/6 04:07 pm Check Earnings Report
US:NASDAQ Investor Relations: investor.alderbio.com/node/5806
Related news 1:14 PM ET The best pharmaceutical stocks to buy have commonalities: Strong Composite Ratings and Relative Strength Ratings. CRISPR Biotech Inks Deal To Use Stem Cells In Gene-Editing Medicine Alder Biopharmaceuticals Earns Relative Strength Rating Upgrade; Hits Key Threshold Novartis Snags A $1.6 Billion Buy That Could Rival These Biotechs Alder Biopharmaceuticals Sees IBD RS Rating Rise To 75 The Hits Just Keep Coming For Biogen As Rival Gains MS Drug Approval Biogen Skids On Alzheimer's Flop — And Unveils Yet Another Study This Pharma Giant Slipped After FDA Rejected Its Diabetes Treatment Alder Biopharmaceuticals Clears Key Benchmark, Hitting 80-Plus RS Rating Novartis ( NVS ) sued its partner Amgen ( AMGN ) on Thursday, accusing the biotech of trying to renege on their agreement to sell migraine treatment Aimovig. The Swiss pharmaceutical company filed a lawsuit in a Manhattan federal court, Reuters reported. Novartis acc Show less Read more
Impact Snapshot
Event Time:
ALDR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for ALDR alerts
Opt-in for
ALDR alerts

from News Quantified
Opt-in for
ALDR alerts

from News Quantified